Follow the latest coverage, related explainers and connected technology stories.
The U.S. Food and Drug Administration (FDA) faces a legal and ethical challenge in its attempt to withdraw the drug "Tavneos" from the markets, amid accusations against "ChemoCentryx" of manipulating clinical trial data to ensure approval.